Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-009932
Filing Date
2022-01-31
Accepted
2022-01-31 21:05:29
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm221700-20_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm221700-20_4seq1.xml 4 9691
  Complete submission text file 0001104659-22-009932.txt   11241
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 60 JUBILEE AVENUE, MILTON PARK ABINGDON OXFORDSHIRE X0 X0 OX14 4R
Business Address
Piccina Cintia (Reporting) CIK: 0001907199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 22576462